Skip to main content
Veterinary Medicines

Narcostart (Sedastart) 1 mg/ml solution for injection for cats and dogs

Authorised
  • Medetomidine hydrochloride

Product identification

Medicine name:
Narcostart (Sedastart) 1 mg/ml solution for injection for cats and dogs
Narcostart 1 mg/ml injekció kutya és macska részére A.U.V.
Active substance:
  • Medetomidine hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Medetomidine hydrochloride
    1.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
  • Intravenous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05CM91
Authorisation status:
  • Valid
Authorised in:
This information is not available for this product.
Package description:
  • 1 x 1 glass vial with 10 ml. Glass (type I) vials closed with bromobutyl rubber closures secured with aluminium crimp caps.
  • 5 x 1 glass vial with 10 ml. Glass (type I) vials closed with bromobutyl rubber closures secured with aluminium crimp caps.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Le Vet. B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • National Food Chain Safety Office
Authorisation number:
  • 2704/X/10 MgSzH ÁTI
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0138/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • France
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Luxembourg
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 14/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."